Baseline effects of non-flavored e-liquids in the in vitro micronucleus assay.
Nonclinical
Genotoxicity
In Vitro
Smart (2019)
a comparative assessment of e-cigarette aerosol extracts and tobacco cigarette smoke extracts on in vitro endothelial cell inflammation response.
Nonclinical
Respiratory Toxicity
In Vitro
Su (2022)
The main e-cigarette component vegetable glycerin enhances neutrophil migration and fibrosis in endotoxin-induced lung injury via p38 MaPK activation.
Nonclinical
Respiratory Toxicity
In Vitro
Su (2023)
Electronic-Cigarette Vehicles and Flavoring affect Lung Function and Immune Responses in a Murine Model.
Nonclinical
Respiratory Toxicity
In Vitro
Szafran (2020)
Genotoxicity evaluation of tobacco and nicotine delivery products: Part Two. In vitro micronucleus assay.
Nonclinical
Genotoxicity
In Vitro
Thorne (2019)
Genotoxicity evaluation of tobacco and nicotine delivery products: Part One. Mouse lymphoma assay.
Nonclinical
Genotoxicity
In Vitro
Thorne (2019)
In Vitro Toxicological Investigation and Risk assessment of E-Cigarette aerosols Based on a Novel Solvent-Free Extraction Method.
Nonclinical
ALL
In Vitro
Wang (2022)
a comparative in vitro toxicity assessment of electronic vaping product e-liquids and aerosols with tobacco cigarette smoke.
Nonclinical
ALL
In Vitro
Wieczorek (2020)
Chemical Elements in Electronic Cigarette Solvents and aerosols Inhibit Mitochondrial Reductases and Induce Oxidative Stress.
Nonclinical
Immunotoxicity
In Vitro
Williams (2020)
E-Cigarette Liquids and aldehyde Flavoring agents Inhibit CYP2a6 activity in Lung Epithelial Cells.
Nonclinical
Respiratory Toxicity
In Vitro
Winters (2023)